Evidence map›Paper›PMID 40362520›Full record

ArticleInternational journal of molecular sciences2025

Neighborhood-Regularized Matrix Factorization for lncRNA-Disease Association Identification.

Jihwan Ha, Kwangsu Kim

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jihwan HaMajor of Big Data Convergence, Division of Data Information Science, Pukyong National University, Busan 48513, Republic of Korea.ORCID 0000-0002-6086-5693
Kwangsu KimDepartment of Scientific Computing, Pukyong National University, Busan 48513, Republic of Korea.ORCID 0000-0001-6626-316X

Funding

National Research Foundation of Korea(NRF) grant funded by the Korea govern-ment(MSIT) 2022R1C1C2003637
6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) have been shown to be integral in a variety of biological processes and significantly influence the progression of several human diseases. Their involvement in disease mechanisms makes them crucial targets for research in disease biomarker identification. Understanding the intricate relationships between lncRNAs and diseases can offer valuable insights for advancing diagnostic, prognostic and therapeutic strategies. In light of this, we propose a recommendation-system-based model utilizing matrix factorization with disease neighborhood regularization to effectively infer disease-related lncRNAs (NRMFLDA). This approach leverages the power of matrix factorization techniques while incorporating disease neighborhood regularization to enhance the accuracy and reliability of lncRNA-disease association predictions. Consequently, NRMFLDA exhibits outstanding performance, achieving AUC scores of 0.9143 and 0.8993 in both leave-one-out and five-fold cross-validation, surpassing the performance of four previous models. This demonstrates its effectiveness and robustness in accurately predicting disease-related lncRNAs. We believe that NRMFLDA will not only provide innovative approaches for uncovering lncRNA-disease associations but also contribute significantly to the identification of novel biomarkers for various diseases, thereby advancing diagnostic and therapeutic strategies.

Indexed as

Computational BiologyGenetic Predisposition to DiseaseRNA, Long NoncodingAlgorithmsBiomarkersHumansBiomarkersRNA, Long NoncodingdiseaselncRNAlncRNA–disease associationmachine learningmatrix factorization

Identifiers

PMID40362520
PMCPMC12072303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.